Skip to main content
Veterinary Medicines

Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats

Authorised
  • Buprenorphine hydrochloride

Product identification

Medicine name:
Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
Buprecare Multidose 0,3 mg/ml raztopina za injiciranje za pse in mačke
Active substance:
  • Buprenorphine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Buprenorphine hydrochloride
    0.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • Presented in a 10 ml amber Type I glass vial with a bromobutyl rubber stopper and flip-off aluminium cap.Pack size: 1 vial with 10 ml solution for injection.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • MR/V/0622/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0453/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • France
  • Germany
  • Greece
  • Hungary
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Slovenian (PDF)
Published on: 23/02/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."